Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-05-15
著者
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
MATSUDA Shin
Center for Hematopoietic Disorders, Ohta Nishinouchi Hospital, The Ohta Foundation
-
TAKEUCHI Jin
Department of Hematology and Rheumatology, Nihon University School of Medicine
-
MITANI Kinuko
Department of Hematology, Dokkyo University School of Medicine
-
三木 義男
癌研ゲノムセンター
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
KOBAYASHI Yukio
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
TOBINAI Kensei
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
HOTTA Tomomitsu
Department of Hematology and Oncology, Tokai University School of Medicine
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Tobinai Kensei
東海大学 医学部
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Miura S
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Seto M
Department Of Hematology And Chemotherapy
-
Seto Masao
愛知県がんセンター研究所 分子腫瘍学部
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
ASAI Osamu
Department of Medicine, Division of Hematology and Oncology, Jikei University School of Medicine
-
USUI Noriko
Department of Medicine, Division of Hematology and Oncology, Jikei University School of Medicine
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
YOSHIBA Fumiaki
Department of Hematology and Oncology, Tokai University School of Medicine
-
Kato Tomoyuki
愛知県がんセンター研究所 疫学予防部
-
Shimoda Kazuya
九州大学 医学部病態情報学
-
Kagami Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Shimoda Kazuya
九州大学 第1内科
-
Naoe Tomoki
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Tsuboi Naoya
Cardiovascular Center Nagoya Daini Red Cross Hospital
-
Tsuboi Naoya
Division Of Cardiology Nagoya Daini Red Cross Hospital
-
Kobayashi Y
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Usubuchi Noriko
国立がんセンター中央病院
-
Usubuchi Noriko
Hematology And Oncology Division National Cancer Center Hospital East
-
Takayama K
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Tsukasaki Kunihiro
Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Hotta Tomomitsu
National Hospital Organization Nagoya Medical Center
-
Hotta Tomomitsu
国立がんセンター中央病院 血液内科
-
Hotta Tomomitsu
東海大学 医学研究科血液腫瘍内科
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center Hospital
-
Uike N
National Kyusyu Cancer Center
-
FUJISAWA Shin
Yokohama City University Medical Center
-
Kagami Yoshitoyo
東海大学 医学部血液･腫瘍内科
-
Kagami Yoshitoyo
名古屋大学医学部附属病院 病理部
-
Kagami Yoshitoyo
東京大学医科学研究所ヒトゲノム解析センター
-
Uoshima Nobuhiko
京都府立医科大学 血液･腫瘍内科学
-
Uoshima Nobuhiko
Matsushita Memorial Hospital Moriguchi Jpn
-
Uoshima Nobuhiko
1st Department Of Internal Medicine Kyoto Prefectureal University Of Medicine
-
Ohno R
Aichi Cancer Center
-
Ohno Ryuzo
琉球大学 医学部血液免疫検査学分野
-
Naoe Tomoki
名古屋大学 医学系研究科血液･腫瘍内科学
-
Naoe Tomoki
大垣市民病院 血液内科
-
Miyawaki Shuichi
琉球大学 医学部血液免疫検査学分野
-
Miyawaki S
Division Of Hematology Tokyo Metropolitan Ohtsuka Hospital
-
Miyawaki Shuichi
Division Of Hematology Saiseikai Maebashi Hospital
-
Miyawaki Shuichi
Leukemia Research Center Saiseikai Maebashi Hospital
-
Usui Noriko
東京慈恵会医科大学附属病院 中央検査部
-
Usui N
Division Of Hematology And Oncology Department Of Medicine Jikei University
-
DOBASHI Nobuaki
Jikei University Hospital
-
AMAGASAKI Taro
Novartis Pharma Japan
-
TAKESHITA Akihiro
The Third Department of Internal Medicine, Hamamatsu University School of Medicine
-
NAITO Kensuke
The Third Department of Internal Medicine, Hamamatsu University School of Medicine
-
DOBASHI Nobuaki
Department of Clinical Oncology and Hematology, School of Medicine, The Jikei University
-
FURUSAWA Shinpei
Department of Hematology, Dokkyo Medical School of Medicine
-
SAITO Kenji
Department of Hematology, Dokkyo Medical School of Medicine
-
MORISHIMA Yasuo
Hematology and Cell Therapy Division, Aichi Cancer Center Hospital
-
OGURA Michinori
Hematology and Cell Therapy Division, Aichi Cancer Center Hospital
-
BESSHO Masami
Department of Hematology, Saitama Medical University, School of Medicine
-
OHNO Ryuzo
Hematology and Cell Therapy Division, Aichi Cancer Center Hospital
-
OGITA Masami
Sapporo National Hospital
-
Yamamoto Kazuhito
Department Of Hematology And Cell Therapy Aichi Cancer Center Hospital
-
Yamamoto Kazuhito
愛知県がんセンター中央病院 血液･細胞療法部
-
Sawa Masashi
Department Of Molecular Medicine And Hematology Nagoya University Graduate School Of Medicine
-
Kajiguchi Tomohiro
Department Of Hematology Nagoya University Graduate School Of Medicine
-
Kanakura Yuzuru
大阪大学 医学系研究科心臓血管外科
-
Dobashi Nobuaki
東京慈恵会医科大学 内科学(血液･腫瘍)
-
Dobashi Nobuaki
Department Of Clinical Oncology And Hematology School Of Medicine The Jikei University
-
Takeuchi Jin
Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Shinagawa K
Okayama Univ. Hospital Okayama Jpn
-
Shinagawa Katsuji
岡山大学 第2内科
-
Tsubaki K
Kinki Univ. School Of Medicine Osaka Jpn
-
Tsubaki Kazuo
Third Department Of Internal Medicine Kinki University School Of Medicine
-
Tsubaki Kazuo
浜松医科大学 第3内科
-
Tsubaki Kazuo
近畿大学 産婦人科
-
Usui N
Jikei University Hospital
-
Hotta T
National Hospital Organization Nagoya Medical Center
-
Hotta Tomomitsu
Department Of Hematology Molecular Medicine Unit Atomic Disease Institute Nagasaki University Gradua
-
Hata Tomoko
Nagasaki University
-
Hata Tomoko
Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University G
-
Mishima Yuko
Cancer Chemotherapy Center Clinical Chemotherapy Japanese Foundation For Cancer Research
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
Bessho Masami
Department Of Hematology Saitama Medical University School Of Medicine
-
Bessho Masami
Department Of Hematology Saitama Medical University
-
Naito Kensuke
The Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
SANO Masayuki
Departments of Internal Medicine Saga Medical School
-
Naoe T
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Sakai Mari
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Shinjo Kaori
浜松医科大学 内科学第3
-
Matsuno Yoshihiro
Department Of Chemotherapy Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospita
-
Sato M
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Sano Masayuki
Niigata Cancer Center Hospital
-
Takeshita A
The Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Tomida Akihiro
癌研究会癌化学療法センター
-
Uike Naokuni
Department Of Hemato-oncology Kyushu Cancer Center
-
Asai Osamu
Department Of Clinical Oncology And Hematology School Of Medicine The Jikei University
-
Minami S
Nagasaki Cml Study Group
-
Minami S
(tottori University) United Graduate School Yamaguchi University
-
Tobinai K
National Cancer Center Hospital Tokyo Jpn
-
Tobinai Kensei
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Shimoda Kazuya
Department Of Internal Medicine Gastroenterology And Hematology Faculty Of Medicine Miyazaki Univers
-
Matsuda Shin
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Kobayashi Yukio
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Naoe Tomoki
Department Of Hematologly And Oncology Nagoya University School Of Medicine
-
Tsukasaki K
Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
MITSUI Yoko
Department of Surgery
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
Usui Noriko
Jikei Univ. Hospital Tokyo Jpn
-
Usui Noriko
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Miyawaki Shuichi
Saiseikai Maebashi Hospital Maebashi Jpn
-
Kobayashi Masayuki
Hematology Division National Cancer Center Hospital
-
Murai Yoshiro
Department Of Hematology Tama Hokubu Medical Center
-
Hotta Tomomitsu
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Hata Tomoko
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Tomita Akihiro
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Shigeno Kazuyuki
Japan Adult Leukemia Study Group Hamamatsu Jpn
-
Yoshiba Fumiaki
Department Of Hematology And Oncology Tokai University School Of Medicine
-
Ogura M
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Miyazawa Keisuke
Department Of Hematology Tokyo Medical University
-
Sunami K
Department Of Hematology National Hospital Organization Okayama Medical Center
-
Shinagawa Katsushi
The Second Department Of Internal Medicine
-
Shinagawa Katsuji
Department Of Biopathological Science Okayama University Graduate School Of Medicine And Dentistry
-
Shinagawa Katsuji
Division Of Hematology/oncology Okayama University Medical School
-
Kawase Takakazu
Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute
-
Tobinai Kensei
National Cancer Center Hospital
-
Tobinai Kensei
Department Of Pharmacotherapy National Cancer Institute
-
Asai Osamu
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Shirai Masato
Department Of Gastroenterology Aichi Cancer Center Hospital
-
Ohno Ryuzo
Department Of Medicine Iii Hamamatsu Medical School
-
Dobashi Nobuaki
Jikei Univ. Hospital Tokyo Jpn
-
Ogura Michinori
Department Of Hematology And Chemotherapy Aichi Cancer Center Hospital
-
Kagami Yoshitoyo
Department Of Pathology School Of Medicine Kurume University
-
Furusawa Shinpei
Department Of Hematology Dokkyo Medical School Of Medicine
-
Furusawa Shinpei
Department Of Hematology Dokkyo University School Of Medicine
-
Matsumoto Yosuke
Department Of Molecular Hematology And Oncology Graduate School Of Medical Science Kyoto Prefectural
-
Moriuchi Yukiyoshi
Nagasaki Cml Study Group Nagasaki Jpn
-
Miyazaki Yoshitsugu
Second Department Of Internal Medicine Nagasaki University Graduate School Of Biomedical Science
-
Saito Kenji
Department Of Applied Chemistry Faculty Of Science Tokyo University Of Science
-
Koshikawa Takashi
Aichi Prefectural College Of Nursing & Health
-
Usui Noriko
Department Of Anatomy Teikyo University School Of Medicine
-
Takeuchi Jin
Department Of Internal Medicine Nihon University School Of Medicine
-
Takeshita Akihiro
The Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Takeshita Akihiro
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Takeshita Akihiro
Department Of Medicine Iii Hamamatsu University School Of Medicine
-
Furusawa S
Department Of Hematology Hamamatsu Medical Center
-
Taguchi Jun
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Taguchi Jun
Department Of Hematology Kanagawa Cancer Center
-
Takeyama K
National Cancer Center Hospital Tokyo Jpn
-
Usui Noriko
Division Of Oncology & Hematology Department Of Internal Medicine The Jikei University School Of
-
Komiyam Y
Akita Univ. School Of Medicine Akita Jpn
-
Kawai Yasukazu
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Maki Kazuhiro
Department Of Hematology Dokkyo University School Of Medicine
-
Naruse T
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Tamura Jun'ichi
Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Miyazaki Yasushi
Department Of Hematology Kinki University School Of Medicine
-
Yano Kunio
県西部浜松医療センター
-
Takeshita Akihiro
Hamamatsu Univ. School Of Medicine Shizuoka Jpn
-
Moritaka S
Department Of Surgery Ii Nagoya City University Medical School
-
Mitani Kinuko
Department Of Hematology Dokkyo Medical University
-
Hotta Tomomitsu
Nagoya Medical Center Nagoya Jpn
-
Sugiyama Katsuki
Division Of Hematology And Oncology Department Of Internal Medicine The Jikei University School Of M
-
Morishima Yasuo
Department Of Pathology And Oncology Institute Of Medical Science University Of Tokyo
-
Ogura Michinori
Department Of Hematology And Chemotherapy Aichi Cancer Center
-
Kimura Yoshizo
Department Of Pathology School Of Medicine Kurume University
-
Tsukasaki Kunihiro
The Department Of Haematology Of Atomic Disease Institute Nagasaki University School Of Medicine
-
Takeuchi Jin
Department Of Hematology And Rheumatology Division Of Medicine Nihon University School Of Medicine
-
Nakano Tatsunori
Second Departmant Of Medicine Nagoya City University Medical School
-
Naito Kensuke
Department Of Hematology Hamamatsu Medical Center
-
Tamura Amane
Hamamatsu Univ. School Of Medicine Shizuoka Jpn
-
Mori Sayaka
Department Of Clinical Laboratory Nagasaki University Hospital
-
MITANI Kinuko
Department of Hematology and Oncology, Dokkyo Medical University School of Medicine
-
SAITO Kenji
Department of Applied Biological Chemistry Graduate School of Agricultural and Life Sciences, The University of Tokyo
関連論文
- ゲノム情報を生かした個別化医療 (特集 固形癌の最新治療--癌治療への新たな取り組み) -- (治療の新たな取り組み 個別化治療)
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- P-674 大腸癌肝転移切除例のSurgical Marginについての遺伝子学的および組織学的検討
- PP-1137 大腸癌肝転移に対する外科的治療戦略 : Surgical Marginについての遺伝子学的および臨床病理学的検討
- SF-107-4 大腸sm癌のリンパ節転移と遺伝子群のマイクロアレイによる解析(第107回日本外科学会定期学術集会)
- 大腸の増殖形式(PG・NPG)と遺伝子群のマイクロアレイによる解析,悪性度についての検討
- マイクロアレイによる大腸癌の異時性肝転移の高リスク群の抽出
- SY-1-2-5 肝細胞癌の進展機構解析による新規分子標的の同定(シンポジウム1-2 消化器癌の発生機序から見た治療戦略-肝胆膵癌,第62回日本消化器外科学会定期学術総会)
- PS-095-1 n0乳癌における再発予後予測システムの検討
- SY-6-6 癌遺伝子発現パターンを用いたPaclitaxelの治療効果予知 : 局所進行乳癌に対する術前化療による解析
- 早期大腸癌の発育形態と Ras-signaling Pathway 異常(第105回日本外科学会定期学術集会)
- PS-117-2 散発性大腸癌発癌におけるhMLH1発現低下の意義
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Enhanced expression of the EVI1 gene in NUP98/HOXA-expressing leukemia cells
- Role of the RUNX1-EVI1 fusion gene in leukemogenesis
- RUNX1/EVI1, which blocks myeloid differentiation, inhibits CCAAT-enhancer binding protein α function
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- Donor cell leukemia after allogeneic peripheral blood stem cell transplantation : a case report and literature review
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy
- Mutational analysis of SOS1 gene in acute myeloid leukemia
- Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan
- Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
- Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
- Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia
- Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Successful Treatment with Imatinib Mesylate of a CML Patient in Megakaryoblastic Crisis with Severe Fibrosis
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- Safety and Efficacy of Autologous Progenitor Cell Transplantation for Therapeutic Angiogenesis in Patients With Critical Limb Ischemia
- Downregulation of microRNAs-143 and -145 in B-cell malignancies
- let-7 MicroRNA Functions as a Potential Growth Suppressor in Human Colon Cancer Cells(Molecular and Cell Biology)
- A Case of Interstitial Pneumonia Induced by Rituximab Therapy
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Chemical Speciation of Arsenic Species in Human Blood Serum by Liquid Chromatography Using a Phosphatidylcholine-Coated ODS Column with Detection by ICP-MS
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Establishment of a Stroma-Dependent Human Acute Myelomonocytic Leukemia Cell Line, NAMO-2, with FLT3 Tandem Duplication
- Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor : A Case Report and Review of the Literature
- High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
- Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
- Two Patients with All-trans Retinoic Acid-Resistant Acute Promyelocytic Leukemia Treated Successfully with Gemtuzumab Ozogamicin as a Single Agent
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- A Prospective Study of Cyclosporine A Treatment of Patients with Low-Risk Myelodysplastic Syndrome : Presence of CD55^-CD59^- Blood Cells Predicts Platelet Response
- Interaction of von Willebrand Factor with the Extracellular Matrix and Glycocalicin under Static Conditions^1
- Feasibility and eligibility of retreatment with rabbit anti-T lymphocyte globulin for aplastic anemia previously treated with horse anti-thymocyte globulin
- Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
- Spontaneous regression of aleukemic leukemia cutis harboring a NPM/RARA fusion gene in an infant with cutaneous mastosytosis
- Biology, Clinical Relevance, and Molecularly Targeted Therapy in Acute Leukemia with FLT3 Mutation
- Nucleophosmin : A versatile molecule associated with hematological malignancies
- Mechanism-based Therapy for Leukemia: A Lesson from Atra Therapy
- Karyotypically independent clones with del(11q) and trisomy 10 in acute myeloid leukemia : trisomy 10 may appear as an additional change
- Antitumor effect of arsenic trioxide in murine xenograft model
- Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
- Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor
- Quality of Life in Adult Patients after Bone Marrow Transplantation
- Successful post-remission therapy with a combination of all-trans retinoic acid and arsenic trioxide in an elderly Japanese patient newly diagnosed with acute promyelocytic leukemia
- Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rγc^ mice
- Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation
- Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
- Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations
- Acute myeloid leukemia in the elderly : 159 Nagoya case studies
- Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines
- Leukemia-related transcription factor TEL/ETV6 expands erythroid precursors and stimulates hemoglobin synthesis
- Toxic effects of arsenic (As^) and other metal ions on acute promelocytic leukemia cells
- Immunoglobulin Variable Region Structure and B-Cell Malignancies
- Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
- Immunoaffinity Purification and Characterization of CACGTG Sequence-Binding Proteins from Cultured Mammalian Cells Using an Anti c-Myc Monoclonal Antibody Recognizing the DNA-Binding Domain
- Histone deacetylase inhibitors trichostatin A and valproic acid circumvent apoptosis in human leukemic cells expressing the RUNX1 chimera
- Low-Level Expression of ETV6/TEL in Patients with Myelodysplastic Syndrome
- TEL/ETV6 Binds to Corepressor KAP1 via the HLH Domain
- Runx1/AML1 in Normal and Abnormal Hematopoiesis
- Low Frequency of BCL10 Gene Mutations in B-Cell Non-Hodgkin's Lymphoma
- Presentation of familial Mediterranean fever in a heterozygous MEFV mutation triggered by immunosuppressive therapy for myelodysplastic syndrome
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment
- Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Chromosomal abnormalities and oncogenes
- Virus-Associated Hemophagocytic Syndrome Caused by Pandemic Swine-Origin Influenza A (H1N1) in a Patient After Unrelated Bone Marrow Transplantation
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance : sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation : macrophage-targeted steroid therapy
- Mutation of ARHGAP9 in patients with coronary spastic angina
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study
- Efficacy and safety of human adipose tissue-derived mesenchymal stem cells for supporting hematopoiesis
- Guest editorial : Introducing progress in hematology in this issue